J Postgrad Med Close
 

Figure 3: Number of messenger Ribonucleic acid (mRNA) copies for matrix metalloproteinases (MMP) 2, MMP9, tissue inhibitor of metalloproteinases‑2 genes calculated in terms of Glyceraldehyde 3‑phosphate dehydrogenase (GAPDH) in the group of acute coronary syndromes patients and control group

Figure 3: Number of messenger Ribonucleic acid (mRNA) copies for matrix metalloproteinases (MMP) 2, MMP9, tissue inhibitor of metalloproteinases‑2 genes calculated in terms of Glyceraldehyde 3‑phosphate dehydrogenase (GAPDH) in the group of acute coronary syndromes patients and control group